Rationale: Cigarette smoking is emerging as a strong risk factor in the otherwise unknown
etiology of chronic inflammatory diseases. Whether the same applies also to smokeless …

The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco),
which is common in Sweden and increasing elsewhere, is receiving increasing attention since …

Background: Previous studies have provided inconsistent results on possible increased risk
of cardiovascular disease with the use of smokeless tobacco. The aim of this study was to …

Background The prevalence of gastro-esophageal reflux disease (GERD) varies widely
around the world. This study aimed to investigate the prevalence and risk factors of GERD in a …

Background The relationship between statin treatment and Coronavirus Disease 2019 (COVID-19)
mortality has been discussed due to the pleiotropic effects of statins on coagulation …

Background: In Sweden, use of smokeless tobacco (oral moist snuff) is common among adult
men. Research on cerebrovascular effects associated with long-term use of snuff is limited …

Data from prospective studies on blood pressure and prostate cancer risk are limited, and
results are inconclusive. Baseline measurements of height, weight and blood pressure were …

There is a male sex disadvantage in morbidity and mortality due to COVID-19. Proposed
explanations to this disparity include gender-related health behaviors, differential distribution of …

Background Oral moist snuff (snus) is discussed as a safer alternative to smoking, and its use
is increasing. Based on its documented effect on blood pressure, we hypothesized that use …

Background The coronavirus disease 2019 (COVID-19) disproportionately affects minority
populations in the USA. Sweden — like other Nordic countries — have less income and …